Evaluation of serum adenosine deaminase levels with components of metabolic syndrome

Journal Title: International Journal of Clinical Biochemistry and Research - Year 2016, Vol 3, Issue 3

Abstract

Introduction: Metabolic syndrome is a major worldwide health problem leading to markedly increased mortality and serious morbidity. The major features of the metabolic syndrome include central obesity, hypertriglyceridemia, low high-density lipoprotein (HDL) cholesterol, hyperglycemia, and hypertension. Adenosine, regulates adipokines secretion by adipose tissue. They will regulate free fatty acid oxidation and it has the capacity to act like insulin on adipose tissue. Increased Adenosine Deaminase(ADA) activity leads to decrease in adenosine in adipose tissue. Since a relationship exists between adenosine deaminase and metabolic syndrome, we have undertaken a preliminary study to determine its plasma activity in metabolic syndrome cases and highlight its importance by comparing its activity with each component of metabolic syndrome. Objectives: To estimate serum ADA, Fasting blood sugar (FBS), Triglyceride (TG), HDL, Waist circumference (WC) & Blood pressure (BP) in cases and controls and to correlate serum ADA with FBS, TG, HDL, WC & BP in cases of Metabolic syndrome. Materials & Methods: The study was conducted on 50 diagnosed cases of Metabolic syndrome and 50 age and sex matched healthy subjects. ADA estimated by Guisti and Gulanti method, FBS by GOD - POD method, HDL-C by Immunoinhibition method, TG by GPO-PAP method, Waist circumference & BP measured as per WHO criteria. Statistical analysis was done using SPSS-17. Results: Serum ADA, FBS & TG levels, waist circumference, Blood Pressure levels were significantly elevated in cases compared to controls. Serum HDL levels was significantly decreased in cases compared to controls. Correlation was positive and significant when ADA activity was compared with FBS, TG, WC & BP and correlation was negative and significant when ADA activity was compared with HDL in cases. Conclusion: These findings clearly project an early detection of elevation of ADA levels may help in early prevention and management of metabolic syndrome and its complications.

Authors and Affiliations

Netravathi Basappa Sajjan, Asmabi Makandar

Keywords

Related Articles

Effect of Hypothyroidism on lipid profile

Objective: To study the effects of subclinical and overt hypothyroidism on serum levels of low density lipoprotein(LDL), total cholesterol(TC), high density lipoprotein (HDL) and triglycerides(TG). And also to compare th...

Comparison of lipid profile and de-ritis ratio in ultrasound diagnosed non-alcoholic and alcoholic fatty liver disease

Introduction: Non-alcoholic fatty liver disease (NAFLD), is a major cause of chronic liver disease. NAFLD can progress to fibrosis, cirrhosis, liver failure and hepatocellular carcinoma, like alcoholic fatty liver diseas...

Oxidative stress in post menopausal women with cardiovascular risk factors

Background: Menopause is a normal occurrence in the life of every woman. As the life expectancy of woman all over the world now increases, a woman has to spend almost 1/3rd of her life in menopause years. Along with the...

Performance verification and sigma metrics of creatinine assays

Introduction: Creatinine enzymatic method is more accurate but its own higher cost is the main reason why the use of Jaffe assays is still in practice. The verification step is performed because assay procedure confirms...

The association of serum uric acid with total white blood cell count in a healthy Indian adult population

Background: Atherosclerosis is the underlying cause for nearly all cases of Coronary Artery Disease (CAD) which is a major cause of mortality in men and women. Numerous studies state that the basic pathology behind ather...

Download PDF file
  • EP ID EP242747
  • DOI -
  • Views 100
  • Downloads 0

How To Cite

Netravathi Basappa Sajjan, Asmabi Makandar (2016). Evaluation of serum adenosine deaminase levels with components of metabolic syndrome. International Journal of Clinical Biochemistry and Research, 3(3), 285-291. https://www.europub.co.uk/articles/-A-242747